{"pmid":32369613,"title":"Effectiveness of a COVID-19 screening questionnaire for pregnant women at admission to an obstetric unit in Milan.","text":["Effectiveness of a COVID-19 screening questionnaire for pregnant women at admission to an obstetric unit in Milan.","Sutton et al. [1] recently reported on universal testing with nasopharyngeal swabs to detect severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection in 215 women admitted for delivery at the Presbyterian Allen Hospital in New York, USA. They identified 33 (15.3%) infected women, of whom only four had fever or symptoms suggesting coronavirus disease 2019 (COVID-19). These findings suggest that only universal testing can reliably recognize infected cases. However, this approach is only feasible in major hospitals in high-resource countries with efficient lab facilities in-house. Alternative approaches deserve consideration.","Int J Gynaecol Obstet","Tassis, Beatrice","Lunghi, Giovanna","Frattaruolo, Maria Pina","Ruggiero, Marta","Somigliana, Edgardo","Ferrazzi, Enrico","32369613"],"abstract":["Sutton et al. [1] recently reported on universal testing with nasopharyngeal swabs to detect severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection in 215 women admitted for delivery at the Presbyterian Allen Hospital in New York, USA. They identified 33 (15.3%) infected women, of whom only four had fever or symptoms suggesting coronavirus disease 2019 (COVID-19). These findings suggest that only universal testing can reliably recognize infected cases. However, this approach is only feasible in major hospitals in high-resource countries with efficient lab facilities in-house. Alternative approaches deserve consideration."],"journal":"Int J Gynaecol Obstet","authors":["Tassis, Beatrice","Lunghi, Giovanna","Frattaruolo, Maria Pina","Ruggiero, Marta","Somigliana, Edgardo","Ferrazzi, Enrico"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32369613","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1002/ijgo.13191","keywords":["covid-19","coronavirus","obstetrics unit","sars-cov-2","screening"],"locations":["New York","USA","Milan"],"countries":["United States","Italy"],"countries_codes":["USA|United States","ITA|Italy"],"topics":["Diagnosis"],"weight":1,"_version_":1666138496140574721,"score":9.490897,"similar":[{"pmid":32428964,"title":"The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19.","text":["The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19.","OBJECTIVE: This study was aimed to compare maternal and pregnancy outcomes of symptomatic and asymptomatic pregnant women with novel coronavirus disease 2019 (COVID-19). STUDY DESIGN: This is a retrospective cohort study of pregnant women with COVID-19. Pregnant women were divided into two groups based on status at admission, symptomatic or asymptomatic. All testing was done by nasopharyngeal swab using polymerase chain reaction (PCR) for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Initially, nasopharyngeal testing was performed only on women with a positive screen (symptoms or exposure) but subsequently, testing was universally performed on all women admitted to labor and delivery. Chi-square and Wilcoxon's rank-sum tests were used to compare outcomes between groups. RESULTS: Eighty-one patients were tested because of a positive screen (symptoms [n = 60] or exposure only [n = 21]) and 75 patients were universally tested (all asymptomatic). In total, there were 46 symptomatic women and 22 asymptomatic women (tested based on exposure only [n = 12] or as part of universal screening [n = 10]) with confirmed COVID-19. Of symptomatic women (n = 46), 27.3% had preterm delivery and 26.1% needed respiratory support while none of the asymptomatic women (n = 22) had preterm delivery or need of respiratory support (p = 0.007 and 0.01, respectively). CONCLUSION: Pregnant women who presented with COVID19-related symptoms and subsequently tested positive for COVID-19 have a higher rate of preterm delivery and need for respiratory support than asymptomatic pregnant women. It is important to be particularly rigorous in caring for COVID-19 infected pregnant women who present with symptoms. KEY POINTS: . Respiratory support is often needed for women who present with symptoms.. . Low rate of severe disease in women who present without symptoms.. . There were no neonatal infections on day 0 of life..","Am J Perinatol","London, Viktoriya","McLaren, Rodney Jr","Atallah, Fouad","Cepeda, Catherine","McCalla, Sandra","Fisher, Nelli","Stein, Janet L","Haberman, Shoshana","Minkoff, Howard","32428964"],"abstract":["OBJECTIVE: This study was aimed to compare maternal and pregnancy outcomes of symptomatic and asymptomatic pregnant women with novel coronavirus disease 2019 (COVID-19). STUDY DESIGN: This is a retrospective cohort study of pregnant women with COVID-19. Pregnant women were divided into two groups based on status at admission, symptomatic or asymptomatic. All testing was done by nasopharyngeal swab using polymerase chain reaction (PCR) for severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). Initially, nasopharyngeal testing was performed only on women with a positive screen (symptoms or exposure) but subsequently, testing was universally performed on all women admitted to labor and delivery. Chi-square and Wilcoxon's rank-sum tests were used to compare outcomes between groups. RESULTS: Eighty-one patients were tested because of a positive screen (symptoms [n = 60] or exposure only [n = 21]) and 75 patients were universally tested (all asymptomatic). In total, there were 46 symptomatic women and 22 asymptomatic women (tested based on exposure only [n = 12] or as part of universal screening [n = 10]) with confirmed COVID-19. Of symptomatic women (n = 46), 27.3% had preterm delivery and 26.1% needed respiratory support while none of the asymptomatic women (n = 22) had preterm delivery or need of respiratory support (p = 0.007 and 0.01, respectively). CONCLUSION: Pregnant women who presented with COVID19-related symptoms and subsequently tested positive for COVID-19 have a higher rate of preterm delivery and need for respiratory support than asymptomatic pregnant women. It is important to be particularly rigorous in caring for COVID-19 infected pregnant women who present with symptoms. KEY POINTS: . Respiratory support is often needed for women who present with symptoms.. . Low rate of severe disease in women who present without symptoms.. . There were no neonatal infections on day 0 of life.."],"journal":"Am J Perinatol","authors":["London, Viktoriya","McLaren, Rodney Jr","Atallah, Fouad","Cepeda, Catherine","McCalla, Sandra","Fisher, Nelli","Stein, Janet L","Haberman, Shoshana","Minkoff, Howard"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32428964","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1055/s-0040-1712164","topics":["Diagnosis"],"weight":1,"_version_":1667252837700075520,"score":179.31798},{"pmid":32438425,"title":"COVID-19 in Pregnant Women: Case Series from One Large New York City Obstetrical Practice.","text":["COVID-19 in Pregnant Women: Case Series from One Large New York City Obstetrical Practice.","OBJECTIVE: This study aimed to report a case series of pregnant women in New York City with confirmed or presumed coronavirus disease (COVID-19) infection. STUDY DESIGN: Beginning March 22, 2020, all pregnant women from one large obstetrical practice in New York City were contacted regularly to inquire about symptoms of COVID-19 (fever, cough, shortness of breath, malaise, anosmia), or sick contacts. A running log was kept of these patients, as well as all patients who underwent COVID-19 testing. For this report, we included every patient with suspected COVID-19 infection, which was defined as at least two symptoms, or a positive COVID-19 nasopharyngeal polymerase chain reaction test. RESULTS: From March 22, 2020 until April 30, 2020, 757 pregnant women in our practice were evaluated and 92 had known or suspected COVID-19 (12.2%, 95% confidence interval [CI]: 10.0-14.7%). Of these 92 women, 33 (36%) had positive COVID-19 test results. Only one woman required hospital admission for 5 days due to COVID-19 (1.1%, 95% CI: 0.2-5.9%). One other woman received home oxygen. No women required mechanical ventilation and there were no maternal deaths. One woman had an unexplained fetal demise at 14 weeks' gestation around the time of her COVID-19 symptoms. Twenty one of the 92 women have delivered, and all were uncomplicated. CONCLUSIONS: Among 92 women with confirmed or presumed COVID-19, the overall morbidity was low. These preliminary results are encouraging for pregnant women during the COVID-19 pandemic. KEY POINTS: . Coronavirus disease (COVID-19) is prevalent in New York City.. . In this case series, COVID-19 in pregnant women had a very low morbidity and no mortality.. . This preliminary data is reassuring for pregnant women at risk of COVID-19..","Am J Perinatol","Fox, Nathan S","Melka, Stephanie","32438425"],"abstract":["OBJECTIVE: This study aimed to report a case series of pregnant women in New York City with confirmed or presumed coronavirus disease (COVID-19) infection. STUDY DESIGN: Beginning March 22, 2020, all pregnant women from one large obstetrical practice in New York City were contacted regularly to inquire about symptoms of COVID-19 (fever, cough, shortness of breath, malaise, anosmia), or sick contacts. A running log was kept of these patients, as well as all patients who underwent COVID-19 testing. For this report, we included every patient with suspected COVID-19 infection, which was defined as at least two symptoms, or a positive COVID-19 nasopharyngeal polymerase chain reaction test. RESULTS: From March 22, 2020 until April 30, 2020, 757 pregnant women in our practice were evaluated and 92 had known or suspected COVID-19 (12.2%, 95% confidence interval [CI]: 10.0-14.7%). Of these 92 women, 33 (36%) had positive COVID-19 test results. Only one woman required hospital admission for 5 days due to COVID-19 (1.1%, 95% CI: 0.2-5.9%). One other woman received home oxygen. No women required mechanical ventilation and there were no maternal deaths. One woman had an unexplained fetal demise at 14 weeks' gestation around the time of her COVID-19 symptoms. Twenty one of the 92 women have delivered, and all were uncomplicated. CONCLUSIONS: Among 92 women with confirmed or presumed COVID-19, the overall morbidity was low. These preliminary results are encouraging for pregnant women during the COVID-19 pandemic. KEY POINTS: . Coronavirus disease (COVID-19) is prevalent in New York City.. . In this case series, COVID-19 in pregnant women had a very low morbidity and no mortality.. . This preliminary data is reassuring for pregnant women at risk of COVID-19.."],"journal":"Am J Perinatol","authors":["Fox, Nathan S","Melka, Stephanie"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32438425","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1055/s-0040-1712529","locations":["New York","New York","New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis"],"weight":1,"_version_":1667521393613340674,"score":170.88342},{"pmid":32292903,"pmcid":"PMC7144599","title":"COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals.","text":["COVID-19 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York City hospitals.","The novel coronavirus 2019, or COVID-19, infection has rapidly spread through the New York metropolitan area since the first reported case in the state on March 1, 2020. New York currently represents an epicenter for COVID-19 infection in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early experience with seven COVID-positive patients in pregnancy, including two women who were diagnosed with COVID-19 following an asymptomatic initial presentation. We now describe a series of 43 test-confirmed cases of COVID-19 presenting to a pair of affiliated New York City hospitals over two weeks from March 13 to 27, 2020. Fourteen (32.6%) patients presented without any COVID-associated viral symptoms, and were identified either after developing symptoms during admission or following the implementation of universal testing for all obstetrical admissions on March 22. Of these, 10/14 (71.4%) developed symptoms or signs of COVID-19 infection over the course of their delivery admission or early after postpartum discharge. Of the other 29 (67.4%) patients who presented with symptomatic COVID-19 infection, three women ultimately required antenatal admission for viral symptoms, and an additional patient represented six days postpartum after a successful labor induction with worsening respiratory status that required oxygen supplementation. There were no confirmed cases of COVID-19 detected in neonates upon initial testing on the first day of life. Applying COVID-19 disease severity characteristics as described by Wu et al, 37 (86%) women possessed mild disease, four (9.3%) exhibited severe disease, and two (4.7%) developed critical disease; these percentages are similar to those described for non-pregnant adults with COVID-19 infections (about 80% mild, 15% severe, and 5% critical disease).","Am J Obstet Gynecol MFM","Breslin, Noelle","Baptiste, Caitlin","Gyamfi-Bannerman, Cynthia","Miller, Russell","Martinez, Rebecca","Bernstein, Kyra","Ring, Laurence","Landau, Ruth","Purisch, Stephanie","Friedman, Alexander M","Fuchs, Karin","Sutton, Desmond","Andrikopoulou, Maria","Rupley, Devon","Sheen, Jean-Ju","Aubey, Janice","Zork, Noelia","Moroz, Leslie","Mourad, Mirella","Wapner, Ronald","Simpson, Lynn L","D'Alton, Mary E","Goffman, Dena","32292903"],"abstract":["The novel coronavirus 2019, or COVID-19, infection has rapidly spread through the New York metropolitan area since the first reported case in the state on March 1, 2020. New York currently represents an epicenter for COVID-19 infection in the United States, with 84,735 cases reported as of April 2, 2020. We previously presented an early experience with seven COVID-positive patients in pregnancy, including two women who were diagnosed with COVID-19 following an asymptomatic initial presentation. We now describe a series of 43 test-confirmed cases of COVID-19 presenting to a pair of affiliated New York City hospitals over two weeks from March 13 to 27, 2020. Fourteen (32.6%) patients presented without any COVID-associated viral symptoms, and were identified either after developing symptoms during admission or following the implementation of universal testing for all obstetrical admissions on March 22. Of these, 10/14 (71.4%) developed symptoms or signs of COVID-19 infection over the course of their delivery admission or early after postpartum discharge. Of the other 29 (67.4%) patients who presented with symptomatic COVID-19 infection, three women ultimately required antenatal admission for viral symptoms, and an additional patient represented six days postpartum after a successful labor induction with worsening respiratory status that required oxygen supplementation. There were no confirmed cases of COVID-19 detected in neonates upon initial testing on the first day of life. Applying COVID-19 disease severity characteristics as described by Wu et al, 37 (86%) women possessed mild disease, four (9.3%) exhibited severe disease, and two (4.7%) developed critical disease; these percentages are similar to those described for non-pregnant adults with COVID-19 infections (about 80% mild, 15% severe, and 5% critical disease)."],"journal":"Am J Obstet Gynecol MFM","authors":["Breslin, Noelle","Baptiste, Caitlin","Gyamfi-Bannerman, Cynthia","Miller, Russell","Martinez, Rebecca","Bernstein, Kyra","Ring, Laurence","Landau, Ruth","Purisch, Stephanie","Friedman, Alexander M","Fuchs, Karin","Sutton, Desmond","Andrikopoulou, Maria","Rupley, Devon","Sheen, Jean-Ju","Aubey, Janice","Zork, Noelia","Moroz, Leslie","Mourad, Mirella","Wapner, Ronald","Simpson, Lynn L","D'Alton, Mary E","Goffman, Dena"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32292903","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.ajogmf.2020.100118","keywords":["covid-19","novel coronavirus","pregnancy"],"locations":["New York","New York","United States","New York","New York"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis"],"weight":1,"_version_":1666138494420910080,"score":155.81175},{"pmid":32439389,"title":"Clinical Characteristics of 46 Pregnant Women with a SARS-CoV-2 Infection in Washington State.","text":["Clinical Characteristics of 46 Pregnant Women with a SARS-CoV-2 Infection in Washington State.","BACKGROUND: The impact of the coronavirus disease 2019 (Covid-19) on pregnant women is incompletely understood, but early data from case series suggest a variable course of illness from asymptomatic or mild disease to maternal death. It is unclear whether pregnant women manifest enhanced disease similar to influenza viral infection or whether specific risk factors might predispose to severe disease. OBJECTIVE: To describe maternal disease and obstetrical outcomes associated with Covid-19 disease in pregnancy to rapidly inform clinical care. STUDY DESIGN: Retrospective study of pregnant patients with a laboratory-confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection from six hospital systems in Washington State between January 21, 2020 and April 17, 2020. Demographics, medical and obstetric history, and Covid-19 encounter data were abstracted from medical records. RESULTS: A total of 46 pregnant patients with a SARS-CoV-2 infection were identified from hospital systems capturing 40% of births in Washington State. Nearly all pregnant individuals with a SARS-CoV-2 infection were symptomatic (93.5%, n=43) and the majority were in their second or third trimester (43.5%, n=20 and 50.0%, n=23, respectively). Symptoms resolved in a median of 24 days (interquartile range 13-37). Seven women were hospitalized (16%) including one admitted to the intensive care unit. Six cases (15%) were categorized as severe Covid-19 disease with nearly all patients being either overweight or obese prior to pregnancy, asthma or other co-morbidities. Eight deliveries occurred during the study period, including a preterm birth at 33 weeks to improve pulmonary status in a woman with Class III obesity. One stillbirth occurred of unknown etiology. CONCLUSIONS: Nearly 15% of pregnant patients developed severe Covid-19, which occurred primarily in overweight or obese women with underlying conditions. Obesity and Covid-19 may synergistically increase risk for a medically-indicated preterm birth to improve maternal pulmonary status in late pregnancy. Collectively, these findings support categorizing pregnant patients as a higher risk group, particularly for those with chronic co-morbidities.","Am J Obstet Gynecol","Lokken, Erica M","Walker, Christie L","Delaney, Shani","Kachikis, Alisa","Kretzer, Nicole M","Erickson, Anne","Resnick, Rebecca","Vanderhoeven, Jeroen","Hwang, Joseph K","Barnhart, Nena","Rah, Jasmine","Mccartney, Stephen A","Ma, Kimberly K","Huebner, Emily M","Thomas, Chad","Sheng, Jessica S","Paek, Bettina W","Retzlaff, Kristin","Kline, Carolyn R","Munson, Jeff","Blain, Michela","Lacourse, Sylvia M","Deutsch, Gail","Adams Waldorf, Kristina","32439389"],"abstract":["BACKGROUND: The impact of the coronavirus disease 2019 (Covid-19) on pregnant women is incompletely understood, but early data from case series suggest a variable course of illness from asymptomatic or mild disease to maternal death. It is unclear whether pregnant women manifest enhanced disease similar to influenza viral infection or whether specific risk factors might predispose to severe disease. OBJECTIVE: To describe maternal disease and obstetrical outcomes associated with Covid-19 disease in pregnancy to rapidly inform clinical care. STUDY DESIGN: Retrospective study of pregnant patients with a laboratory-confirmed severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection from six hospital systems in Washington State between January 21, 2020 and April 17, 2020. Demographics, medical and obstetric history, and Covid-19 encounter data were abstracted from medical records. RESULTS: A total of 46 pregnant patients with a SARS-CoV-2 infection were identified from hospital systems capturing 40% of births in Washington State. Nearly all pregnant individuals with a SARS-CoV-2 infection were symptomatic (93.5%, n=43) and the majority were in their second or third trimester (43.5%, n=20 and 50.0%, n=23, respectively). Symptoms resolved in a median of 24 days (interquartile range 13-37). Seven women were hospitalized (16%) including one admitted to the intensive care unit. Six cases (15%) were categorized as severe Covid-19 disease with nearly all patients being either overweight or obese prior to pregnancy, asthma or other co-morbidities. Eight deliveries occurred during the study period, including a preterm birth at 33 weeks to improve pulmonary status in a woman with Class III obesity. One stillbirth occurred of unknown etiology. CONCLUSIONS: Nearly 15% of pregnant patients developed severe Covid-19, which occurred primarily in overweight or obese women with underlying conditions. Obesity and Covid-19 may synergistically increase risk for a medically-indicated preterm birth to improve maternal pulmonary status in late pregnancy. Collectively, these findings support categorizing pregnant patients as a higher risk group, particularly for those with chronic co-morbidities."],"journal":"Am J Obstet Gynecol","authors":["Lokken, Erica M","Walker, Christie L","Delaney, Shani","Kachikis, Alisa","Kretzer, Nicole M","Erickson, Anne","Resnick, Rebecca","Vanderhoeven, Jeroen","Hwang, Joseph K","Barnhart, Nena","Rah, Jasmine","Mccartney, Stephen A","Ma, Kimberly K","Huebner, Emily M","Thomas, Chad","Sheng, Jessica S","Paek, Bettina W","Retzlaff, Kristin","Kline, Carolyn R","Munson, Jeff","Blain, Michela","Lacourse, Sylvia M","Deutsch, Gail","Adams Waldorf, Kristina"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32439389","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1016/j.ajog.2020.05.031","keywords":["covid-19","sars-cov-2","asthma","coronavirus","fetal death","infection","maternal morbidity","obesity","overweight","pregnancy","preterm birth","respiratory insufficiency","stillbirth"],"locations":["Washington State","Washington State","obese","obese","Washington State"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis"],"weight":1,"_version_":1667535119487860736,"score":142.70444},{"pmid":32459701,"title":"Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.","text":["Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.","OBJECTIVE: To characterize symptoms and disease severity among pregnant women with coronavirus disease 2019 (COVID-19) infection, along with laboratory findings, imaging, and clinical outcomes. METHODS: Pregnant women with COVID-19 infection were identified at two affiliated hospitals in New York City from March 13 to April 19, 2020, for this case series study. Women were diagnosed with COVID-19 infection based on either universal testing on admission or testing because of COVID-19-related symptoms. Disease was classified as either 1) asymptomatic or mild or 2) moderate or severe based on dyspnea, tachypnea, or hypoxia. Clinical and demographic risk factors for moderate or severe disease were analyzed and calculated as odds ratios (ORs) with 95% CIs. Laboratory findings and associated symptoms were compared between those with mild or asymptomatic and moderate or severe disease. The clinical courses and associated complications of women hospitalized with moderate and severe disease are described. RESULTS: Of 158 pregnant women with COVID-19 infection, 124 (78%) had mild or asymptomatic disease and 34 (22%) had moderate or severe disease. Of 15 hospitalized women with moderate or severe disease, 10 received respiratory support with supplemental oxygen and one required intubation. Women with moderate or severe disease had a higher likelihood of having an underlying medical comorbidity (50% vs 27%, OR 2.76, 95% CI 1.26-6.02). Asthma was more common among those with moderate or severe disease (24% vs 8%, OR 3.51, 95% CI 1.26-9.75). Women with moderate or severe disease were significantly more likely to have leukopenia and elevated aspartate transaminase and ferritin. Women with moderate or severe disease were at significantly higher risk for cough and chest pain and pressure. Nine women received ICU or step-down-level care, including four for 9 days or longer. Two women underwent preterm delivery because their clinical status deteriorated. CONCLUSION: One in five pregnant women who contracted COVID-19 infection developed moderate or severe disease, including a small proportion with prolonged critical illness who received ICU or step-down-level care.","Obstet Gynecol","Andrikopoulou, Maria","Madden, Nigel","Wen, Timothy","Aubey, Janice J","Aziz, Aleha","Baptiste, Caitlin D","Breslin, Noelle","D'Alton, Mary E","Fuchs, Karin M","Goffman, Dena","Gyamfi-Bannerman, Cynthia","Matseoane-Peterssen, Dara N","Miller, Russell S","Sheen, Jean-Ju","Simpson, Lynn L","Sutton, Desmond","Zork, Noelia","Friedman, Alexander M","32459701"],"abstract":["OBJECTIVE: To characterize symptoms and disease severity among pregnant women with coronavirus disease 2019 (COVID-19) infection, along with laboratory findings, imaging, and clinical outcomes. METHODS: Pregnant women with COVID-19 infection were identified at two affiliated hospitals in New York City from March 13 to April 19, 2020, for this case series study. Women were diagnosed with COVID-19 infection based on either universal testing on admission or testing because of COVID-19-related symptoms. Disease was classified as either 1) asymptomatic or mild or 2) moderate or severe based on dyspnea, tachypnea, or hypoxia. Clinical and demographic risk factors for moderate or severe disease were analyzed and calculated as odds ratios (ORs) with 95% CIs. Laboratory findings and associated symptoms were compared between those with mild or asymptomatic and moderate or severe disease. The clinical courses and associated complications of women hospitalized with moderate and severe disease are described. RESULTS: Of 158 pregnant women with COVID-19 infection, 124 (78%) had mild or asymptomatic disease and 34 (22%) had moderate or severe disease. Of 15 hospitalized women with moderate or severe disease, 10 received respiratory support with supplemental oxygen and one required intubation. Women with moderate or severe disease had a higher likelihood of having an underlying medical comorbidity (50% vs 27%, OR 2.76, 95% CI 1.26-6.02). Asthma was more common among those with moderate or severe disease (24% vs 8%, OR 3.51, 95% CI 1.26-9.75). Women with moderate or severe disease were significantly more likely to have leukopenia and elevated aspartate transaminase and ferritin. Women with moderate or severe disease were at significantly higher risk for cough and chest pain and pressure. Nine women received ICU or step-down-level care, including four for 9 days or longer. Two women underwent preterm delivery because their clinical status deteriorated. CONCLUSION: One in five pregnant women who contracted COVID-19 infection developed moderate or severe disease, including a small proportion with prolonged critical illness who received ICU or step-down-level care."],"journal":"Obstet Gynecol","authors":["Andrikopoulou, Maria","Madden, Nigel","Wen, Timothy","Aubey, Janice J","Aziz, Aleha","Baptiste, Caitlin D","Breslin, Noelle","D'Alton, Mary E","Fuchs, Karin M","Goffman, Dena","Gyamfi-Bannerman, Cynthia","Matseoane-Peterssen, Dara N","Miller, Russell S","Sheen, Jean-Ju","Simpson, Lynn L","Sutton, Desmond","Zork, Noelia","Friedman, Alexander M"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32459701","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1097/AOG.0000000000003996","locations":["New York","hypoxia"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Diagnosis"],"weight":1,"_version_":1667967698999443457,"score":141.18039}]}